Non–Small Cell Lung Cancer: Other Actionable Mutations
2 Tampilan
• 07/04/23
0
0
Menanamkan
administrator
Pelanggan
Corey J. Langer, MD; V****iliki Papadimitrakopoulou, MD; and Hossein Borghaei, DO, elucidate the potential value of less common actionable mutations in determining appropriate treatment for patients with non–small cell lung cancer.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru